OncLive - Bringing the Oncology Community Together

Angeles Alvarez Secord, MD, discusses the available treatment modalities for patients with platinum-sensitive and -resistant recurrent ovarian cancer. Read More >>

Statistics Show Increase in US Cancer Survivors

Key Trials Showcase the Utility of Neratinib in HER2+ Breast Cancer

Zanubrutinib Continues to Show Encouraging Activity in Relapsed/Refractory MCL

Report Highlights Struggle to Help Survivors Prepare for Life After Treatment

Expert Explains Evolution of De-Escalating Therapies in HER2+ Breast Cancer

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Genitourinary Cancers in Jacksonville

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

Dr. Lee Highlights Key Takeaways From SPARTAN Trial in M0CRPC

Dr. Hou on the Latest Updates With CAR T-Cell Therapy in DLBCL

Dr. Shadman on the CLL14 Trial in CLL

Dr. Messersmith on the Rise of Molecular Testing in mCRC

Dr. El-Khoueiry on Choosing Between Immunotherapy Agents and TKIs in HCC

Dr. Redner on the Potency of Gilteritinib in AML

Dr. Yu on Initial Findings From the KEYNOTE-365 Trial in mCRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Molecular Testing for NSCLC in 2019

Acting on Molecular Testing Results in NSCLC

Stage III Melanoma: Neoadjuvant Therapy

Stage III Melanoma: Changes to Staging System

Genetic Risk, Screening, and Diagnosis for Gastric Cancer

Introduction and Global Trends of Gastric Cancer

MONALEESA-2 and Choosing Among the CDK4/6

OncLive houses thousands of videos that provide updates and information.
See more Videos

Frontline Treatment Regimens in Follicular Lymphoma

Initiating Therapy in Follicular Lymphoma

Factors to Consider in Choosing ALK TKIs in Frontline Setting

Safety/Efficacy Experience With Ramucirumab in HCC

VEGF-Targeted Therapy in HCC: Ramucirumab

Frontline-Therapy Decision Factors for mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates

Pivotal trial data were presented at the 2018 ASH Annual Meeting that demonstrated promising results for the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL).

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

FDA Approvals in Myeloma and ITP, Applications Accepted in Myeloma and More